
Andrew has been supporting the execution of pharmaceutical capital projects on the front range of CO for the last seven years. Starting at AstraZeneca, Andrew provided Project Support and Construction Management for the startup of a GMP Warehouse acquired from the previous owner, Amgen. In addition to his project support he also provided consulting, audit and technical writing support to the environmental health and safety group. Andrew then provided PM and Facilities & Engineering support to Novartis Gene Therapies in Colorado (formerly AveXis). More recently, Andrew was an Associate Project Manager for a $66MM project for Catalent Pharma Solutions in Maryland, and most recently, the PM for Vernal Biosciences in VT. Andrew is dedicated to meeting his clients goals through excellent communication, objective-focused management, and results-oriented project delivery.
Contracted to Catalent Pharma Solutions (MD), Catalent Davis (NC), and Vernal Biosciences (VT)
Contracted to Avexis, Inc and Novartis Gene Therapies
Contracted to AstraZeneca (CO)
CAPM - Certified Associate Project Manager
ISPE - International Society for Pharmaceutical Engineers
PMI - Project Management Institute